Yannian Gou, Yanran Huang, Wenping Luo, Yanan Li, Piao Zhao, Jiamin Zhong, Xiangyu Dong, Meichun Guo, Aohua Li, Ailing Hao, Guozhi Zhao, Yonghui Wang, Yi Zhu, Hui Zhang, Yunhan Shi, William Wagstaff, Hue H Luu, Lewis L Shi, Russell R Reid, Tong-Chuan He, Jiaming Fan
Effective bone regeneration through tissue engineering requires a combination of osteogenic progenitors, osteoinductive biofactors and biocompatible scaffold materials. Mesenchymal stem cells (MSCs) represent the most promising seed cells for bone tissue engineering. As multipotent stem cells that can self-renew and differentiate into multiple lineages including bone and fat, MSCs can be isolated from numerous tissues and exhibit varied differentiation potential. To identify an optimal progenitor cell source for bone tissue engineering, we analyzed the proliferative activity and osteogenic potential of four commonly-used mouse MSC sources, including immortalized mouse embryonic fibroblasts (iMEF), immortalized mouse bone marrow stromal stem cells (imBMSC), immortalized mouse calvarial mesenchymal progenitors (iCAL), and immortalized mouse adipose-derived mesenchymal stem cells (iMAD)...
April 2024: Bioactive Materials